Serum-free solutions for cryopreservation of cells

In Vitro Cellular and Developmental Biology - Animal

Volumn 43, Issue 8-9, 2007, Pages 269-275

  Campbell, Lia H ^a   Brockbank, Kelvin G M ^a  

^a Cell and Tissue Systems Inc   (United States)

Author keywords

Cytotoxicity; Freezing; Serum; Viability

Indexed keywords

ARTIFICIAL TEAR; DIMETHYL SULFOXIDE; EURO COLLINS SOLUTION; PROPYLENE GLYCOL;

ARTICLE; CELL POPULATION; CELL SURVIVAL; CELL VIABILITY; CRYOPRESERVATION; CRYOPROTECTION; HOMEOSTASIS; NONHUMAN;

ANIMALS; CATTLE; CELL LINE; CELL SURVIVAL; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; DIMETHYL SULFOXIDE; PROPYLENE GLYCOLS; SERUM; SOLUTIONS;

EID: 38149003042     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-007-9039-z     Document Type: Article

References (44)

1. Asher, D. M. The transmissible spongiform encephalopathy agents: concerns and responses of United States regulatory agencies in maintaining the safety of biologics. Dev. Biol Stand. 100:103-118; 1999.
2. Baust, J. M. Molecular mechanisms of cellular demise associated with cryopreservation failure. Cell Preservation Technologies 1:17-32; 2002.
3. Baust, J. M.; van Buskirk, R. G.; Baust, J. G. Improved Cryopreservation Outcome is Facilitated by an Intracellular-Type medium and Inhibition of Apoptosis. Journal of the Biomedical Engineering Society 1:206-207; 1999.
4. Baust, J. M.; Van Buskirk, R.; Baust, J. G. Gene activation of the apoptotic caspase cascade following cryogenic storage. Cell Preservation Technologies 1:63-80; 2002a.
5. Baust, J. M.; Van Buskirk, R.; Baust, J. G. Modulation of the cryopreservation cap: elevated survival with reduced dimethyl sulfoxide concentration. Cryobiology 45:97-108; 2002b.
6. Baust, J. M.; Vogel, M. J.; van Buskirk, R. G.; Baust, J. G. A Molecular Basis of Cryopreservation Failure and its Modulation to Improve Cell Survival. Cell Transplantation 10:561-571; 2001.
7. Bielanski, A.; Bergeron, H.; Lau, P. C.; Devenish, J. Microbial contamination of embryos and semen during long term banking in liquid nitrogen. Cryobiology 46:146-152; 2003.
8. Bradley, R. Bovine spongiform encephalopathy and its relationship to the variant form of Creutzfeldt-Jakob disease. Contrib. Microbiol. 11:146-185; 2004.
9. Brown, P.; Will, R. G.; Bradley, R.; Asher, D. M.; Detwiler, L. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution, and current concerns. Emerg. Infect. Dis. 7:6-16; 2001.
10. Campbell, L. H.; Taylor, M. J.; Brockbank, K. G. M. U.S. Patent #6,596,531 Two stage method for thawing cryopreserved cells; 2003.
11. Committee for Veterinary Medicinal Products. Guideline on Requirements and Controls Applied to Bovine Serum used in the Production of Immunological Veterinary Medicinal Products. EMEA/CVMP/743-00; 2001.
12. Croes, E. A. and van Duijn, C. M. Variant Creutzfeldt-Jakob disease. Eur J Epidemiol 18:473-477; 2003.
13. Erickson, G. A.; Bolin, S. R.; Landgraf, J. G. Viral contamination of fetal bovine serum used for tissue culture: risks and concerns. Dev. Biol Stand. 75:173-175; 1991.
14. Erickson, G. A.; Landgraf, J. G.; Wessman, S. J.; Koski, T. A.; Moss, L. M. Detection and elimination of adventitious agents in continuous cell lines. Dev. Biol Stand. 70:59-66; 1989.
15. FDA International Conference on Harmonisation. Guidance on quality of biotechnological/biological products: derivation and characterization of cell substrates used for production of biotechnological/biological products; availability. Notice. Food and Drug Administration, HHS. Fed. Regist. 63:50244-50249; 1998.
16. Food and Drug Administration. BSE Estimating Risks for vCJD in Vaccines Using Bovine-Derived Materials. http://www.fda.gov/cber/bse/risk.htm ; 2001.
17. Froud, S. J. The development, benefits and disadvantages of serum-free media. Dev. Biol Stand. 99:157-166; 1999.
18. Hubálek, Z. Protectants used in the cryopreservation of microorganisms. Cryobiology 46:205-229; 2003.
19. Irani, D. N. and Johnson, R. T. Diagnosis and prevention of bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. Annu Rev Med 54:305-319; 2003.
20. Ironside, J. W. and Head, M. W. Variant Creutzfeldt-Jakob disease and its transmission by blood. J Thromb Haemost 1:1479-1486; 2003.
21. Jayme, D. W. An animal origin perspective of common constituents of serum-free medium formulations. Dev. Biol Stand. 99:181-187; 1999.
22. Jennings, A. Detecting viruses in sera: methods used and their merits. Dev. Biol Stand. 99:51-59; 1999.
23. Lakey, J. R. T.; Rajotte, R. V.; Fedorow, C. A.; Taylor, M. J. Islet Cryopreservation using Intracellular Preservation Solutions. Cell Transplant 10:583-589; 2001.
24. Levings, R. L. and Wessman, S. J. Bovine viral diarrhea virus contamination of nutrient serum, cell cultures and viral vaccines. Dev. Biol Stand. 75:177-181; 1991.
25. Makoschey, B.; van Gelder, P. T.; Keijsers, V.; Goovaerts, D. Bovine viral diarrhoea virus antigen in foetal calf serum batches and consequences of such contamination for vaccine production. Biologicals 31:203-208; 2003.
26. Merten, O. W. Safety issues of animal products used in serum-free media. Dev. Biol Stand. 99:167-180; 1999.
27. Nuttall, P. A.; Luther, P. D.; Stott, E. J. Viral contamination of bovine foetal serum and cell cultures. Nature 266:835-837; 1977.
28. Pegg, D. E.; Wusteman, M. C.; Boylan, S. Fractures in cryopreserved elastic arteries: mechanism and prevention. Cryobiology 33:658-659; 1996.
29. Schlumpf, R.; Morel, Ph.; Loveras, J. J.; Condie, R. M.; Matas, A.; Kurle, J.; Najarian, J. S.; Sutherland, D. E. R. Examination of the Role of the Colloids Hydroxyethylstarch, Dextran, Human Albumin, and Plasma Proteins in a Modified UW Solution. Transplantation Proceedings 23:2362-2365; 1991.
30. Shiiya, N.; Paul, M.; Bevenuti, C.; Astier, A.; Ferrer, M.-J.; Loisance, D. A. Lactobionate-based Extracellular-type Solution for Donor Heart Preservation. Journal of Heart and Lung Transplantation 12:476-483; 1993.
31. Southard, J. H.; van Gulik, T. M.; Ametani, M. S.; Vreugdenhil, P. K.; Lindell, S. L.; Pienaar, B. L.; Belzer, F. O. Important Components of the UW Solution. Transplantation 49:251-257; 1990.
32. Sumimoto, R.; Dohi, K.; Urushihara, T.; Jamieson, N. V.; Ito, H.; Sumimoto, K.; Fukuda, Y. An Examination of the Effects of Solutions Containing Histidine and Lactobionate for Heart, Pancreas, and Liver Preservation in the Rat. Transplantation 53:1206-1210; 1992.
33. Taylor, M. J. The Role of pH"and Buffer Capacity in the Recovery of Function of Smooth Muscle cooled to -13 C in Unfrozen Media. Cryobiology 19:585-601; 1982.
34. Taylor, M. J. Biology of cell survival in the cold: The Basis for Biopreservation of Tissues and Organs. In: Baust, J. G. ed. Advances in Biopreservation. Boca Raton: CRC Press; 2004.
35. Taylor, M. J.; Campbell, L. H.; Rutledge, R. N.; Brockbank, K. G. M. Comparison of Unisol(TM) with EuroCollins Solution as a Vehicle Solution for Cryoprotectants. Transplantation Proceedings 33:677-679; 2001.
36. Taylor, M. J. and Hunt, C. J. A new preservation solution for storage of corneas at low temperatures. Current Eye Research 4:963-973; 1985.
37. Taylor, M. J. and Pignat, Y. Practical acid dissociation constants, temperature coefficients and buffer capacities for some biological buffers in solutions containing dimethyl sulfoxide between 25 and -12° C. Cryobiology 19:99-109; 1982.
38. Taylor, M. J.; Walter, C. A.; Elford, B. C. The pH-dependent recovery of smooth muscle from storage at -13 C in unfrozen media. Cryobiology 15:452-460; 1978.
39. Trevitt, C. R. and Singh, P. N. Variant Creutzfeldt-Jakob disease: pathology, epidemiology, and public health implications. Am. J Clin. Nutr. 78:651S-656S; 2003.
40. Ward, H. J.; Head, M. W.; Will, R. G.; Ironside, J. W. Variant Creutzfeldt-Jakob disease. Clin. Lab Med 23:87-108; 2003.
41. Weber, D. J. Biosafety Considerations for Cell-based Therapies. BioPharm International; 2004.
42. Wessman, S. J. and Levings, R. L. Benefits and risks due to animal serum used in cell culture production. Dev. Biol Stand. 99:3-8; 1999.
43. Will, R. G.; Ironside, J. W.; Zeidler, M.; Cousens, S. N.; Estibeiro, K.; Alperovitch, A.; Poser, S.; Pocchiari, M.; Hofman, A.; Smith, P. G. A new variant of Creutzfeldt-Jakob disease in the UK. The Lancet 347:921-925; 1996.
44. Zabal, O.; Kobrak, A. L.; Lager, I. A.; Schudel, A. A.; Weber, E. L. Contamination of bovine fetal serum with bovine viral diarrhea virus. Rev Argent Microbiol. 32:27-32; 2000.